Clinical Trial Update: Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating oral nicorandil for microvascular function in women with non-obstructive coronary artery disease was terminated, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-obstructive Coronary Artery Disease

Drugs mentioned

• Nicorandil (nicorandil)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Non-obstructive Coronary Artery Disease | Phase 4 | Status: TERMINATED | Results posted: 2020-07-07